Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Other Non-Current Liabilities: 2014-2024

Historic Other Non-Current Liabilities for Viridian Therapeutics, Inc.\DE (VRDN) over the last 9 years, with Dec 2024 value amounting to $2.3 million.

  • Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities rose 19.48% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 19.48%. This contributed to the annual value of $2.3 million for FY2024, which is 133.37% up from last year.
  • According to the latest figures from FY2024, Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities is $2.3 million, which was up 133.37% from $989,000 recorded in FY2023.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities registered a high of $2.3 million during FY2024, and its lowest value of $43,000 during FY2020.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities averaged around $1.5 million, with its median value being $1.2 million (2022).
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first spiked by 2,709.30% in 2021, then fell by 15.61% in 2023.
  • Yearly analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities stood at $43,000 in 2020, then soared by 2,709.30% to $1.2 million in 2021, then dropped by 2.98% to $1.2 million in 2022, then fell by 15.61% to $989,000 in 2023, then spiked by 133.37% to $2.3 million in 2024.